225Ac-J591
1706018281
Phase 2 small_molecule active
Quick answer
225Ac-J591 for Prostate Cancer is a Phase 2 program (small_molecule) at United Therapeutics Europe Ltd with 2 ClinicalTrials.gov record(s).
Program details
- Company
- United Therapeutics Europe Ltd
- Indication
- Prostate Cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active